Discovery of a spiroindane based compound as a potent, selective, orally bioavailable melanocortin subtype-4 receptor agonist. (Q51774599)
Jump to navigation
Jump to search
scientific article published on 19 February 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Discovery of a spiroindane based compound as a potent, selective, orally bioavailable melanocortin subtype-4 receptor agonist. |
scientific article published on 19 February 2010 |
Statements
1 reference
Discovery of a spiroindane based compound as a potent, selective, orally bioavailable melanocortin subtype-4 receptor agonist. (English)
1 reference
1 reference
D Euan Macintyre
1 reference
Alison M Strack
1 reference
Shuwen He
1 reference
Zhixiong Ye
1 reference
Peter H Dobbelaar
1 reference
Iyassu K Sebhat
1 reference
Liangqin Guo
1 reference
Jian Liu
1 reference
Tianying Jian
1 reference
Yingjie Lai
1 reference
Christopher L Franklin
1 reference
Raman K Bakshi
1 reference
James P Dellureficio
1 reference
Qingmei Hong
1 reference
Nancy N Tsou
1 reference
Richard G Ball
1 reference
Doreen E Cashen
1 reference
David H Weinberg
1 reference
Tanya Macneil
1 reference
Rui Tang
1 reference
Constantin Tamvakopoulos
1 reference
Qianping Peng
1 reference
Randy R Miller
1 reference
Ralph A Stearns
1 reference
Howard Y Chen
1 reference
Airu S Chen
1 reference
Tung M Fong
1 reference
Matthew J Wyvratt
1 reference
Ravi P Nargund
1 reference
19 February 2010
1 reference
20
1 reference
2106-2110
1 reference
7
1 reference
1 reference
Identifiers
1 reference